Silke Gillessen, Prof

Trials

Studies that name Silke Gillessen, Prof as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:01 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT05974774 · Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

  European Organisation for Research and Treatment of Cancer - EORTC · recruiting · Prostate Cancer · study chair
• Ph2
  NCT02933801 · ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

  Swiss Cancer Institute · terminated · Prostate Cancer Metastatic, Prostate Cancer · study chair
• Ph3
  NCT02194842 · Phase III Radium 223 mCRPC-PEACE III

  European Organisation for Research and Treatment of Cancer - EORTC · active not recruiting · Prostate Cancer · study chair
• Ph3
  NCT02053311 · Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

  Swiss Cancer Institute · withdrawn · Prostate Cancer · study chair
• Ph3
  NCT02051218 · Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

  Swiss Cancer Institute · terminated · Metastatic Breast Cancer, Metastatic Prostate Cancer, Bone Metastases · study chair
• Ph3
  NCT01707966 · Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

  Swiss Cancer Institute · completed · Prostate Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.